References
- Gjerde G, Naess H. Risk factor burden predicts long-term mortality after cerebral infarction. Acta Neurol Scand. 2014;129:173–77. doi:https://doi.org/10.1111/ane.12159.
- Gondim FA, Cruz-Flores S, Moore J. Angioplasty and stenting for symptomatic basilar artery stenosis. J Neuroimaging. 2002;12:55–58. doi:https://doi.org/10.1111/j.1552-6569.2002.tb00090.x.
- Zhang MJ, Zhang X, Xu YX. Analysis on value of CT and MRI clinical application in diagnosis of middle-aged patients with multiple cerebral infarction. Int J Clin Exp Med. 2015;8(10):17123–27.
- Zhang W, Cheng J, Zhang Y, Wang K, Jin H. Analysis of CT and MRI Combined Examination for the Diagnosis of Acute Cerebral Infarction. J Coll Physicians Surg Pak. 2019;29(9):898–99.doi:https://doi.org/10.29271/jcpsp.2019.09.898.
- Yang B, Shi X, Dai M, Xu C, You F, Fu F, Liu R, Dong X. Real-time imaging of cerebral infarction in rabbits using electrical impedance tomography. J Int Med Res. 2014;42(1):173–83.doi:https://doi.org/10.1177/0300060513499100.
- Myszka W, Wierzchowiecki M, Torliński L, Dziegielewska S. Ischemia modified albumin–a new biochemical marker of myocardial ischemia. Pol Arch Med Wewn. 2005;114(6):1252–59.
- Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J, Mookadam F, Hill SA. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ. 2005;172:1685–90. doi:https://doi.org/10.1503/cmaj.045194.
- Lippi G, Montagnana M, Salvagno GL, Guidi GC. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM. 2006;8:27–31. doi:https://doi.org/10.1017/S148180350001335X.
- Sokhanvar S, Mellati AO, Mousavinasab SN, Taran L, Vahdani B, Golmmohamadi Z. Ischemia-modified albumin (IMA) in differential diagnosis of transient myocardial ischemia from non ischemic chest pain. Bratisl Lek Listy. 2012;113:612–15.
- Abboud H, Labreuche J, Meseguer E, Lavallee PC, Simon O, Olivot JM, Mazighi M, Dehoux M, Benessiano J, Steg PG, Amarenco P. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis. 2007;23:216–20. doi:https://doi.org/10.1159/000097644.
- Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Karahan SC, Topbas M, Aydin M, Eraydin I, Akcan B. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med. 2008;26:874–78. doi:https://doi.org/10.1016/j.ajem.2007.11.023.
- Nayak AR, Kashyap RS, Kabra D, Purohit HJ, Taori GM, Daginawala HF. Prognostic significance of ischemia-modified albumin in acute ischemic stroke patients: a preliminary study. Ann Neurosci. 2011;18:5–7. doi:https://doi.org/10.5214/ans.0972.7531.1118103.
- Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem. 2001;268(1):42–47.doi:https://doi.org/10.1046/j.1432-1327.2001.01846.x.
- Bhakthavatsala Reddy C, Cyriac C, Desle HB. Role of “Ischemia Modified Albumin” (IMA) in acute coronary syndromes. Indian Heart J. 2014;66:656–62. doi:https://doi.org/10.1016/j.ihj.2014.12.005.
- Mishra B, Pandey S, Niraula SR, Rai BK, Karki P, Baral N, Lamsal M. Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome. J Nepal Health Res Counc. 2018;16:16–21. doi:https://doi.org/10.3126/jnhrc.v16i1.19383.
- Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem. 2001;47:464–70. doi:https://doi.org/10.1093/clinchem/47.3.464.
- Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of “Ischemia modified albumin,” a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J. 2004;21:29–34. doi:https://doi.org/10.1136/emj.2003.006007.
- Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, Gaze D, Collinson P, Carlos Kaski J. Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol. 2004;97:297–301. doi:https://doi.org/10.1016/j.ijcard.2004.05.042.
- Seshadri Reddy V, Bukke S, Munikumar M. Elevated levels of the circulatory ischemia-modified albumin in patients with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2018;34:868–74. doi:https://doi.org/10.1080/09513590.2018.1462318.
- Sahin A, Turkoglu S, Tunc N, Duzenci D, Solmaz OA, Bahcecioglu IH, Yalniz M. Is ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis? Ther Clin Risk Manag. 2018;14:627–35. doi:https://doi.org/10.2147/TCRM.S162690.
- Seshadri Reddy V, Munikumar M, Duggina P, Varma N. A diagnostic test accuracy meta-analysis of maternal serum ischemia-modified albumin for detection of preeclampsia. J Matern Fetal Neonatal Med. 2019;32:2173–81. doi:https://doi.org/10.1080/14767058.2018.1427724.
- Can S, Akdur O, Yildirim A, Adam G, Cakir DU, Karaman HI. Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases. Pak J Med Sci. 2015;31:1110–14. doi:https://doi.org/10.12669/pjms.315.7702.
- Ding LD, Xiao ZH, Mao HW, Hang XF, Guo JH, Ke KF, Chen J. 2021. Ischemia Modified Albumin and miR-126 Play Important Role in Diagnosis of Posterior Circulation Transient Ischemic Attack and Prediction of Secondary Cerebral Infarction. Neurol India. 69(1):75–80. doi:https://doi.org/10.4103/0028-3886.310100
- Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, Kaski JC. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem. 2004;50:1656–60. doi:https://doi.org/10.1373/clinchem.2004.031690.
- Han K, Jia N, Yang L, Min LQ. Correlation between ischemia-modified albumin and lipid levels in patients with acute cerebrovascular disease. Mol Med Rep. 2012;6:621–24. doi:https://doi.org/10.3892/mmr.2012.961.
- Wu AH, Morris DL, Fletcher DR, Apple FS, Christenson RH, Painter PC. Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol. 2001;1:147–51. doi:https://doi.org/10.1385/CT:1:2:147.
- Ulugol H, Aksu U, Kocyigit M, Kilercik M, Karduz G, Okten M, Toraman F. Comparative Effects of Blood and Crystalloid Cardioplegia on Cellular Injury and Oxidative Stress in Cardiovascular Surgery. Ann Thorac Cardiovasc Surg. 2019;25:10–17. doi:https://doi.org/10.5761/atcs.oa.18-00113.
- Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart. 2006;92:113–14. doi:https://doi.org/10.1136/hrt.2004.049643.
- Cichota LC, Moresco RN, Duarte MM, Da Silva JE. Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J Clin Lab Anal. 2008;22:1–5. doi:https://doi.org/10.1002/jcla.20226.
- Yazıcı MU, Ayar G, Savas-Erdeve S, Azapağası E, Neşelioğlu S, Ö E, Çetinkaya S. Role of Ischemia Modified Albumin Serum Levels as an Oxidative Stress Marker in Children with Diabetic Ketoacidosis. Comb Chem High Throughput Screen. 2019;22(8):577–81.doi:https://doi.org/10.2174/1386207322666191008214919.